Alzheimer’s Drugs Market Grow at 9.5% Global Size, Segments Overview, Competitive Share Analysis, New Technology, Upcoming Developments and Business Outlook To 2025
SEATTLE, March 24, 2021, (PHARMIWEB) — Global Alzheimer’s Drugs Market – Young Prospect for Aging Patient
Alzheimer’s disease is a progressive disorder that causes brain cells to deteriorate and die. It is a type of dementia that affects comprehension, behavior, and memory of patient. It is one of the most common and largest form of dementia and is observed in people aged 65 years and above. The primary reason behind Alzheimer’s is accumulation of protein called as beta amyloid in spaces between nerve cells due to genetic mutation. Although Alzheimer’s disease is not treatable, symptomatic treatment is followed in all cases. Research is being carried out to develop treatment centered on the role of beta-amyloid in Alzheimer’s disease.
The global Alzheimer’s drugs market was valued at US$ 7 billion in 2016 and is expected to witness a CAGR of 9.5% over the forecast period (2017 – 2025).
To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/1373
Figure 1. Global Alzheimer’s Drugs Market (US$ Bn), by Region, 2016
Market Dynamics-
Growing prevalence of Alzheimer’s disease to drive growth of the global Alzheimer’s drugs market worldwide
Increasing prevalence and incidence of Alzheimer’s disease worldwide is expected to drive the growth of global Alzheimer’s drugs market during the forecast period. According to World Alzheimer Report in 2016, an estimated 46.5 million people were suffering from Alzheimer’s disease and the number is projected to reach 50 million by 2017, every three second there is new patient of Alzheimer’s disease worldwide.
Growing age and increasing geriatric population are major factors driving growth of the global Alzheimer’s drugs market over the forecast period. For instance, according to World Population Prospects (WPP) published by United Nations in 2017, an estimated 962 million people are of age 60 years or above, which accounted for 13% of the global population. The number is projected to reach 1.4 billion by 2030, growing with annual rate of 3 percent. Europe currently has highest geriatric population (25% of population), Asia Pacific had geriatric population of 547 million people and it is projected to reach 900 million by 2025, therefore these regions have potential opportunity for growth of the market. India has more than 1 million cases of Alzheimer’s disease annually. North America holds dominant position in the global Alzheimer’s drugs market with estimated 5.5 million patients in 2017. This is owing to robust healthcare infrastructure and the region being an early adopter of novel technologies.
Exclusive offer!!! Purchase the report at a discounted rate!!!
Apply Promo Code “CMIFIRST1000” and Get Up to 30% Discount
Quick Buy – Alzheimer’s Drugs Market Research Report: https://bit.ly/3sdvx3o
Large number of undiagnosed patient’s and revised diagnostic guidelines to propel growth the global Alzheimer’s drugs market
People suffering from Alzheimer’s and dementia do not get proper access to the healthcare infrastructure to diagnose and treat the disease. For instance according to World Alzheimer Report in 2016, only around 50% patients suffering from dementia undergo diagnosis. According to the same source, the rate of underdiagnoses is 10% in low and middle income economies, therefore, it is expected to propel growth of the global Alzheimer’s drugs market. Moreover, as of 2011, there were no standard guidelines for diagnosis of disease. Currently, biomarker tests involving amount of beta-amyloid in the brain, which can be visualized in positron emission tomography imaging are under research to diagnosis develop treatment for Alzheimer’s disease. Currently, there is no curative therapy available for Alzheimer’s disease. However, drugs for Alzheimer’s therapy are in pipeline, which are expected to launch in near future, which in turn is propelling growth of the global Alzheimer’s drugs market in the near future.
Competitive Landscape
Key players operating in global Alzheimer’s drugs market include Pfizer, Inc., Janssen Pharmaceutical, Novartis International AG, Eisai Co. Ltd., Lundbeck A/S and Teva Pharmaceuticals Industries Ltd., Other prominent players whose products are under clinical trials are Eli Lilly and Company, TauRx Pharmaceuticals Ltd, VTV Therapeutics, Hoffman-La Roche Ltd., AstraZeneca plc, and AC Immune.
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/alzheimers-drugs-market-to-surge-beyond-us-15-billion-by-2025-695
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drugs
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Key Highlights
- Pipeline Analysis
- Regulatory Guidelines
- Epidemiology
- Market Dynamics
- Global Alzheimer’s Drugs Market, By Drugs, 2015 – 2025, (US$ Million)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016 – 2025
- Segment Trends
- Donepezil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
- Rivastigmine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
- Galantamine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
- Memantine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
- Introduction
- Global Alzheimer’s Drugs Market, By Distribution Channel, 2015 – 2025, (US$ Million)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016 – 2025
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
- e-Commerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
- Introduction
- Global Alzheimer’s Drugs Market, By Region, 2015 – 2025, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, For Regions, 2016 – 2025
- North America
- Market Size and Forecast, By Drugs, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Drugs, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Drugs, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drugs, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Drugs, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drugs, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2015 – 2025, (US$ Million)
- Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profiles
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Editor Details
-
Company:
- CDN Newswire
